Avaliação diagnóstica da cardiomiopatia hipertrófica em fase clínica e pré-clínica: [revisão]

Mattos, Beatriz Piva e; Torres, Marco Antonio Rodrigues; Freitas, Valéria Centeno de.
Arq. bras. cardiol ; 91(1): 55-62, jul. 2008. tab
Artículo en Inglés, Portugués | LILACS | ID: lil-486810

Documentos relacionados

  1. [New guidelines on the diagnostic and therapeutic management of hypertrophic cardiomyopathy].
  2. Diagnostic yield of hypertrophic cardiomyopathy in first-degree relatives of decedents with idiopathic left ventricular hypertrophy.
  3. Circulating Levels of MicroRNAs in Hypertrophic Cardiomyopathy: The Relationship With Left Ventricular Hypertrophy, Left Atrial Dilatation and Ventricular Depolarisation-Repolarisation Parameters.
  4. Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy.
  5. Beyond Sarcomeric Hypertrophic Cardiomyopathy: How to Diagnose and Manage Phenocopies.
  6. Application of Genetic Testing in Unveiling the Diagnosis of Fabry Disease in a Patient with Hypertrophic Cardiomyopathy.
  7. Hypertrophic Cardiomyopathy: Genetic Foundations, Outcomes, Interconnections, and Their Modifiers.
  8. A Validation Study of the Mayo Clinic Phenotype-Based Genetic Test Prediction Score for Japanese Patients With Hypertrophic Cardiomyopathy.
  9. Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging.
  10. [The levels of certain circulating microRNAs in hypertrophic cardiomyopathy are associated with echocardiographic parameters].